Lifeforce and Toku Partner to Use AI Retinal Scans for Health Insights

Lifeforce and Toku have announced a partnership to integrate AI retinal scans with a longevity medicine platform, aiming to slow aging and reduce cardiovascular risk.

Lifeforce and Toku have announced a nationwide partnership to integrate AI retinal scans with the world's largest longevity medicine platform. Announced in a press release, this collaboration aims to transform routine eye exams into opportunities for early health insights and proactive intervention.

The partnership will leverage Toku's BioAge™ wellness product and its forthcoming CLAiR™ technology, which has received the FDA Breakthrough Device designation. CLAiR™ is designed to assess cardiovascular risk using retinal imaging and AI, with anticipated FDA approval in 2026.

Through this collaboration, individuals who undergo a BioAge analysis will be connected to Lifeforce's comprehensive longevity platform. This platform offers at-home diagnostics, access to board-certified longevity physicians, and personalized health protocols, enabling participants to take data-driven steps toward extending their healthspan.

We hope you enjoyed this article.

Consider subscribing to one of several newsletters we publish like Life AI Weekly.

Also, consider following us on social media:

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more